Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Denver Health
mi
from
Denver, CO
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Denver Health
mi
from
Denver, CO
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
University of Colorado- Health Science Center
mi
from
Denver, CO
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
University of Colorado- Health Science Center
mi
from
Denver, CO
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
The Hartford Hospital
mi
from
Hartford, CT
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Kentucky Neuroscience Research
mi
from
Louisville, KY
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Kentucky Neuroscience Research
mi
from
Louisville, KY
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
University of Massachusettes, Worcester Medical Center
mi
from
Worcester, MA
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
University of Massachusettes, Worcester Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Henry Ford Health System
mi
from
Detroit, MI
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Ingham Regional Medical Center
mi
from
Lansing, MI
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Ingham Regional Medical Center
mi
from
Lansing, MI
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Henepin County Medical Center
mi
from
Minneapolis, MN
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Henepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
St Luke's Health System
mi
from
Kansas City, MO
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
St Luke's Health System
mi
from
Kansas City, MO
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Duke University Hopsital
mi
from
Durham, NC
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Duke University Hopsital
mi
from
Durham, NC
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
University of Cincinnati
mi
from
Cincinnati, OH
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated:  7/20/2015
Toronto Western Hospital
mi
from
Toronto,
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
Status: Enrolling
Updated: 7/20/2015
Toronto Western Hospital
mi
from
Toronto,
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Phoenix, AZ
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Atlanta, GA
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Baltimore, MD
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Teaneck, NJ
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Gilbert, AZ
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Danbury, CT
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Fort Wayne, IN
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Boston, MA
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Golden Valley, MN
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Golden Valley, MN
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Patchogue, NY
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Patchogue, NY
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Cleveland, OH
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Dayton, OH
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Portland, OR
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Cordova, TN
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Cordova, TN
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Franklin, TN
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated:  7/21/2015
Clinical Research Facility
mi
from
Milwaukee, WI
BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects With Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNβ) or Glatiramer Acetate (GA)
Status: Enrolling
Updated: 7/21/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
Status: Enrolling
Updated:  7/21/2015
Convergence Medical Devices
mi
from
Boston, MA
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography
Status: Enrolling
Updated: 7/21/2015
Convergence Medical Devices
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of LEDs on Memory in TBI Patients
Treatment of Cognitive Dysfunction in Mild TBI With Transcranial Light Emitting Diodes- An Open Protocol, Pilot Study
Status: Enrolling
Updated:  7/23/2015
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Effects of LEDs on Memory in TBI Patients
Treatment of Cognitive Dysfunction in Mild TBI With Transcranial Light Emitting Diodes- An Open Protocol, Pilot Study
Status: Enrolling
Updated: 7/23/2015
Spaulding Rehabilitation Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated:  7/23/2015
University of Arizona
mi
from
Tucson, AZ
Whole Body Hyperthermia Registry Study
Status: Enrolling
Updated: 7/23/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
LAC-USC Medical Center Los Angeles
mi
from
Los Angeles, CA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
LAC-USC Medical Center Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Huntington Memorial Hospital
mi
from
Pasadena, CA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Huntington Memorial Hospital
mi
from
Pasadena, CA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Miami / Jackson Memorial Medical Center
mi
from
Miami, FL
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Miami / Jackson Memorial Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Southeastern Clinical Research Consultants
mi
from
Orlando, FL
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Southeastern Clinical Research Consultants
mi
from
Orlando, FL
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Orlando Regional Healthcare, Critical Care Medicine
mi
from
Orlando, FL
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Orlando Regional Healthcare, Critical Care Medicine
mi
from
Orlando, FL
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
G&G Research
mi
from
Vero Beach, FL
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
G&G Research
mi
from
Vero Beach, FL
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Orthopaedic Center of Vero Beach
mi
from
Vero Beach, FL
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Orthopaedic Center of Vero Beach
mi
from
Vero Beach, FL
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Medical College of Georgia
mi
from
Augusta, GA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Iowa Hospitals and Clinics, Dept. of Anesthesia
mi
from
Iowa City, IA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Iowa Hospitals and Clinics, Dept. of Anesthesia
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Outcomes Research Institute
mi
from
Louisville, KY
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Outcomes Research Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Louisiana State University, Dept. of Orthopaedic Surgery
mi
from
Shreveport, LA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Louisiana State University, Dept. of Orthopaedic Surgery
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Spectrum Health-Blodgett Campus
mi
from
Grand Rapids, MI
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Spectrum Health-Blodgett Campus
mi
from
Grand Rapids, MI
Click here to add this to my saved trials